Meyka AI API is live for developers.Start building.
Advertisement
Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (INBS) Stock Overview

Explore Intelligent Bio Solutions Inc.’s financial performance, market position, analyst ratings, and future outlook.

INBSNASDAQ
HealthcareMedical - Diagnostics & Research
$2.45
$0.010(0.41%)
U.S. Market opens in 51h 32m
Advertisement

Intelligent Bio Solutions Inc. (INBS)

Meyka AI Score

Z

Key Financials

Market Cap1.6M
P/E Ratio-0.33
EPS (TTM)$-11.62
ROE-1.74%
Fundamental Analysis

AI Price Forecasts

1 Month$2.67
3 Months$6.29
1 Year Target$0.00

INBS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Intelligent Bio Solutions Inc. (INBS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.33 and a market capitalization of 1.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.03%
5-Day Change
-3.21%
1-Month Change
-0.41%
3-Month Change
-43.69%
6-Month Change
-66.76%
Year-to-Date (YTD) Change
-74.71%
1-Year Change
-84.65%
3-Year Change
-99.35%
5-Year Change
-99.97%
All-Time (Max) Change
-99.99%

Contact Information

646 828 8258
142 West 57th Street, New York City, NY, 10019

Company Facts

50 Employees
IPO DateDec 23, 2020
CountryUS
Actively Trading

Frequently Asked Questions